The Current Ratio as of September 2024 (TTM) for Legend Biotech Corporation (LEGN) is 4.84

According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.84. This represents a change of -25.62% compared to the average of 6.51 of the last 4 quarters.

Legend Biotech Corporation (LEGN) Historical Current Ratio (quarterly & annually)

How has LEGN Current Ratio performed in the past?

The mean historical Current Ratio of Legend Biotech Corporation over the last ten years is 3.68. The current 4.84 Current Ratio has changed 13.05% with respect to the historical average. Over the past ten years (40 quarters), LEGN's Current Ratio was at its highest in in the September 2023 quarter at 8.61. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Legend Biotech Corporation (LEGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Legend Biotech Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Legend Biotech Corporation (LEGN) Average Current Ratio

How has LEGN Current Ratio performed in the past?

The current Current Ratio of Legend Biotech Corporation (LEGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Legend Biotech Corporation (LEGN) Current Ratio vs. Peers

How is LEGN’s Current Ratio compared to its peers?

Legend Biotech Corporation’s Current Ratio is less than Vaxcyte, Inc. (17.88), less than Apellis Pharmaceuticals, Inc. (5.08), greater than Travere Therapeutics, Inc. (3.04), less than Akero Therapeutics, Inc. (24.89), less than IVERIC bio, Inc. (15.53), greater than Blueprint Medicines Corporation (3.71), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Karuna Therapeutics, Inc. (19.31), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Zai Lab Limited (3.46), greater than Seagen Inc. (2.67), greater than Alnylam Pharmaceuticals, Inc. (3.01), greater than Ascendis Pharma A/S (0.74), less than 89bio, Inc. (13.92), less than Madrigal Pharmaceuticals, Inc. (8.72), less than Pliant Therapeutics, Inc. (14.47), less than Arcellx, Inc. (6.01), less than Stoke Therapeutics, Inc. (6.67), less than Mirati Therapeutics, Inc. (7.54), less than Terns Pharmaceuticals, Inc. (21.02),

Build a custom stock screener for Legend Biotech Corporation (LEGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Legend Biotech Corporation (LEGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.